Methods are disclosed utilizing DCL, a metabolic derivative of loratadine, for the treatment of allergic rhinitis, and other disorders, while avoiding the concomitant liability of adverse side-effects associated with other non-sedating antihistamines.

 
Web www.patentalert.com

> Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use

~ 00343